Erratum to: A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo

Erratum to: Cancer Immunol Immunother DOI 10.1007/s00262-009-0754-z

Unfortunately, in the original publication under the Section “Results” the sentence in the first paragraph for the subheading “Hu1A12 inhibits OPN-mediated anti-apoptotic and prosurvival functions” is incorrectly published as “In the presence of OPN, [3H]thymidine uptake increased 3.08 ± 0.64-fold in MDA-MB-435S cells (Fig. 5a). However, this incorporation uptake decreased 2.76 ± 0.35-fold when hu1A12 was added” but the correct version is “In the presence of OPN, [3H]thymidine uptake increased 5.02 ± 0.94-fold in MDA-MB-435S cells (Fig. 5a). However, this incorporation uptake decreased 3.17 ± 0.62-fold when hu1A12 was added”.

Figure 5 has been published incorrectly. Please find below the correct version of Fig. 5.